Moreover, additional work confirmed that butyrate and propionate, but not acetate, impact the rate of lipolysis via their shared activity as HDAC inhibitors in 3T3-L1 adipocytes, thus suggesting a possible molecular pathway to mitigate obesity-related outcomes [165]. This evidence concerns the gene HDAC9 and obesity due to melanocortin 4 receptor deficiency.